Download This Document

Total Page:16

File Type:pdf, Size:1020Kb

Download This Document Mahendran, J. (2015) Sylhetisation, dependence and ambivalence: a qualitative exploration of paan use amongst older Bangladeshi women in London. PhD thesis. Bath: Bath Spa University. ResearchSPAce http://researchspace.bathspa.ac.uk/ Your access and use of this document is based on your acceptance of the ResearchSPAce Metadata and Data Policies, as well as applicable law:- https://researchspace.bathspa.ac.uk/policies.html Unless you accept the terms of these Policies in full, you do not have permission to download this document. This cover sheet may not be removed from the document. Please scroll down to view the document. Sylhetisation, Dependence and Ambivalence: A Qualitative Exploration of Paan Use Amongst Older Bangladeshi Women in London JANAKI MAHENDRAN A thesis submitted in partial fulfillment of the requirements of Bath Spa University for the degree of Doctor of Philosophy School of Society, Enterprise and Environment May 2015 ABSTRACT This thesis introduces a novel and alternative way of understanding paan addiction among Bangladeshi women by exploring their lived experiences. There is growing medical evidence that Paan, a mixture of betel leaf, areca nut, tobacco and white lime, is injurious to health, causing cancer, oral disease and addiction (WHO, 2004). Paan use is prevalent and visible among the Bangladeshi community in East London. However, paan dependence is principally examined through the dominant medical model, which prioritises the scientific and pharmacological aspects. Research has yet to examine paan dependence from the user’s perspective, which limits health and social care professionals from understanding the practice, the determinants of the habit and the elements contributing to its continued use. Understanding the user perspective would assist in designing and delivering appropriate and targeted interventions. There are no similar studies of this nature into paan use and therefore this study developed a theoretical framework by examining literature pertaining to migration, biographies and inequalities of health. Method: An ethnographic study was conducted and data collected through extensive fieldwork followed by in-depth interviews with thirty Bangladeshi women in Tower Hamlets, East London, who have continuously used paan over a number of years. Participants were recruited through purposive sampling. Interview data was analysed thematically using grounded theory techniques (Glazer and Strauss, 1967) and then triangulated to compare and crosscheck the consistency of the research findings. Findings: Key research findings indicate that while health discourses have explained paan use simply as a result of physical addiction to tobacco, exploring the biographical, historical and social context of paan use developed a deeper understanding of how the participants constituted the experience and meaning of paan addiction. Four key themes emerged - physical and psychological addiction, availability and social acceptance of paan chewing, lack of involvement in the wider social environment and ‘Sylhetisation’, (a concept introduced by this thesis to describe how the Bangladeshi community have created an environment similar to that of Sylhet). The main recommendation is that an understanding of the sociocultural aspects of paan use may help greatly in developing more culturally specific paan cessation strategies within tobacco policies. ACKNOWLEDGEMENTS In this project I have travelled an unfamiliar path and reached a destination far from where I began. Several people guided and supported me during this difficult time. I would like to thank all those without whom I could not have completed this thesis, my dream project ever since I started working with the Bangladeshi women who had inspired me. My first thanks goes to the Bangladeshi women who welcomed me into their homes and gave me the opportunity to listen to their nostalgic tales of two homes. I am very grateful to my supervisors, Rosemary Mckechnie, Rob Mears and Nod Miller who guided me with their wise counsel and unfailing support. My family has always been my great strength in all my academic adventures. Without their love and support I could not have completed this task. My two colleagues Alesa Rahman and Swapna Mookerji were the gate keepers for Bangladeshi groups and also assisted me to gain an understanding of Bangladeshi culture, Sylheti and the Bengali language. They were always ready to help me with arranging groups for my visits as well as talks and discussions for clarifications afterwards. Their support for me was immense. I am thankful to professors Croucher, Warnakulasuriya and Eade for giving their valuable time to meet me and give valuable advice based on their wisdom related to the topic of the study. I am also indebted to the staff of the Royal London Hospital and School of Dentistry and the community leaders in Tower Hamlets who contributed to my knowledge. I cannot forget the enormous support given to me by the shop keepers, the trading standards officers, the local authority officials and many residents during my fieldwork. My heartfelt thanks go to them. My dear friend Dr Kusum Joshi, who has always supported me in my endeavours, helped me to proofread this thesis. I am grateful to her. AUTHOR’S DECLARATION I declare that the work in this thesis was carried out in accordance with the Regulations of the Bath Spa University. The work is original except where indicated by special reference in the texts and no part of the thesis has been submitted for any other degree. Any views expressed in the thesis are those of the author and no way represent those of the Bath Spa University. The thesis has not been presented to any other University for examination either in the United Kingdom or overseas. Signed Date …………………………. ………………….. DEDICATION To my late parents whose life of compassion and tolerance taught me to overcome the hardships of life with creativity. GLOSSARY Bangladeshi People of Bangladeshi origin Banglalog Bangla people Bidesh foreign Bhuth ghost Eid an annual Islamic festival marking the end of Ramadan Gorelog white people Gua areca nut Gutka pocket size tobacco products Koran Holy book of Islam Londonis people who have travelled from Sylhet to London, or their relations Nani grandmother Paan betel leaves or the mixture of the same with areca nut tobacco and slaked lime Paan masala same as above or pocket size paan products Ramadan A month of fasting, 9th month of the Islamic calendar Supari betel leaves Sylheti associated with Sylhet (people, language or commodities) Zarda/ zada tobacco powder/ tobacco leaf CONTENTS CHAPTER 1: INTRODUCTION Introduction 1 Aims of the research 3 Current key issues associated with paan use 4 Paan products 7 Rationale for this approach 12 The research design 15 Outline of remaining chapters 16 CHAPTER 2: BACKGROUND TO THE STUDY Introduction 19 Health and illness: explaining inequalities 21 Health inequalities 23 Ethnicity and Health 26 Gender inequalities in health 29 The role of paan in Asian culture 32 Healing qualities of areca nut and betel leaf 34 Cultural explanations and migrant health 35 Health and illness narrative and lay knowledge 39 Research related to paan use within the Bangladeshi population 43 Government interventions and public policy 47 Current provision for paan prevention: a medical point of view 50 Summary 54 CHAPTER 3 METHODOLOGY: THE NATURAL HISTORY OF MY RESEARCH Introduction 56 Rationale for ethnography 59 Insider/outsider perspectives in doing ethnography 62 Ethical considerations 68 Phase 1: Fieldwork 71 Investigating key stakeholders 73 Meeting with Health Professionals 75 Meeting with local Bangladeshi people 77 Participant observation 78 Field work visits and observations 82 Focus groups 82 Phase two: In-depth interviews 86 Constructing a sampling strategy 86 In-depth interviews 90 Interview process 93 Data Analysis 95 Reflections: Methodological lessons learned 99 Conclusion 103 CHAPTER 4: TOWER HAMLETS, SYLHET AND BANGLADESHI WOMEN Introduction 105 Tower Hamlets: Home for the Bangladeshi women 106 A brief history of racism and intolerance 108 Sylhet: The land of ‘Londonis’ 118 Sylhet migrants then and now 122 Bangladeshi women 127 Cultural dynamics of transition 130 Conclusion 134 CHAPTER 5: RESEARCH FINDINGS: EXPERIENCING PAAN ADDICTION/ DEPENDENCE Introduction 136 Medical definitions of addiction 138 Neurobiological adaptation (first layer) 140 Manifestations of addiction (second layer) 145 i) Drug addiction and emotion: feeling different 146 ii) Preoccupation with behaviour 149 iii) Temporary satiation 153 iv) Loss of control 156 v) Negative consequences 160 Need for Paan cessation projects 166 Conclusion 170 CHAPTER 6: RESEARCH FINDINGS: EXPERIENCES OF CREATING HOME Introduction 172 Nostalgic memories 175 Missing home 180 Getting used to marital life 181 Arriving in Britain/ Language problems 185 Hostilities and achievements 188 Paan was not a problem then/availability 191 ‘Sylhetisation’/creating home 194 Incorporating Sylhet features in Whitechapel 199 Caring role of women 200 Younger generation 204 Effects of sylhetisation 206 Lack of wider social involvement 209 Segregation and uncertainty 213 Change of attitudes 216 CHAPTER 7: CONCLUSION AND RECOMMENDATIONS Introduction 222 To what extent were the aims of the research fulfilled 224 The main areas of agreement and difference between the 226 respondents Connections between findings and other research 228 The way forward 230 Integrating appropriate intervention programmes of paan cessation 231 Education
Recommended publications
  • Harm Reduction Journal Biomed Central
    Harm Reduction Journal BioMed Central Research Open Access My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India Michelle Kermode*1, Verity Longleng2, Bangkim Chingsubam Singh2, Jane Hocking3, Biangtung Langkham2 and Nick Crofts1 Address: 1Nossal Institute for Global Health, University of Melbourne, Carlton, Victoria, Australia, 2c/- Project ORCHID, CBCNEI Mission Compound, Guwahati, Assam, India and 3Key Centre for Women's Health, University of Melbourne, Carlton, Victoria, Australia Email: Michelle Kermode* - [email protected]; Verity Longleng - [email protected]; Bangkim Chingsubam Singh - [email protected]; Jane Hocking - [email protected]; Biangtung Langkham - [email protected]; Nick Crofts - [email protected] * Corresponding author Published: 5 December 2007 Received: 3 July 2007 Accepted: 5 December 2007 Harm Reduction Journal 2007, 4:19 doi:10.1186/1477-7517-4-19 This article is available from: http://www.harmreductionjournal.com/content/4/1/19 © 2007 Kermode et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The north-east Indian states of Manipur and Nagaland are two of the six high HIV prevalence states in the country, and the main route of HIV transmission is injecting drug use. Understanding the pathways to injecting drug use can facilitate early intervention with HIV prevention programs. While several studies of initiation into injecting drug use have been conducted in developed countries, little is known about the situation in developing country settings.
    [Show full text]
  • Immediate Effect of Tobacco Chewing in the Form of 'Paan'
    April-June 1988 Ind. J. Physiol. Pharmac. e and high altitude stress on humans. behaviour and pituitary adrenal axis IMMEDIATE EFFECT OF TOBACCO CHEWING IN THE FORM of corticosteroids in lactating goats OF 'PAAN' ON CERTAIN CARDIO-RESPIRATORY PARAMETERS r lactating rats : Parallel changes P. K. NANDA AND M. M. SHARMA I-hydroxy corticosteroids in human Department of Physiology, Indira Gandhi Medical College, Shimla - 171 001 on serum transaminase and lactic of Physiological Sciences, New Delhi (Received on May 17, 1987 ) ofstress on serum enzyme levels in Summary: Immediate effect of tobacco in the form of chewing was evaluated in 40 healthy males (mean age 26.27 yrs.) not habituated to tobacco, who were given paan containing 200 mg of of drug metabolizing enzymes and tobacco to chew (group T). Heart rate (HR), blood pressure (BP), forced vital capacity (FVC), nal stress, Ind. J. Med, Res., 83 : FEV} and peak expiratory flow rate (PEFR) were measured twice for each subject, once before chewing and again immediately after completion of chewing. Another 24 age and sex matched ry and clearace in sheep before and controls (group C) were given paan without tobacco to chew and cardiorespiratory parameters 1970. were recorded as for group T subjects. Electrocardiography was recorded in lO group T and 10 ase Process" Ed. J. M. Raamsey , group C subjects. Effect of tobacco chewing was also evaluated in 10 habitual tobacco chewers. Results showed statistically significant increments in HR and BP as well as a decline in T wave of serum Glutamic oxalacetic and amplitude in ECG following tobacco chewing (group T subjects).
    [Show full text]
  • IMS Data Reference Tables
    IMS REFERENCE DATA – VERSION 1.7 TABLES 1. Substance .............................................................................................................................................................................. 2 2. Local Authority ....................................................................................................................................................................... 6 3. Drug Action Team (DAT) ...................................................................................................................................................... 13 4. Nationality ........................................................................................................................................................................... 17 5. Ethnicity ............................................................................................................................................................................... 22 6. Sexual Orientation ............................................................................................................................................................... 22 7. Religion or Belief .................................................................................................................................................................. 22 8. Employment Status .............................................................................................................................................................. 23 9. Accommodation Status
    [Show full text]
  • OCTOBER 2019 Network Bulletin an Important Message from Unitedhealthcare to Health Care Professionals and Facilities
    OCTOBER 2019 network bulletin An important message from UnitedHealthcare to health care professionals and facilities. Enter UnitedHealthcare respects the expertise of the physicians, health care professionals and their staff who participate in our network. Our goal is to support you and your patients in making the most informed decisions regarding the choice of quality and cost-effective care, and to support practice staff with a simple and predictable administrative experience. The Network Bulletin was developed to share important updates regarding UnitedHealthcare procedure and policy changes, as well as other useful administrative and clinical information. Where information in this bulletin conflicts with applicable state and/or federal law, UnitedHealthcare follows such applicable federal and/or state law. UnitedHealthcare Network Bulletin October 2019 Table of Contents Front & Center PAGE 3 Stay up to date with the latest news and information. UnitedHealthcare Commercial PAGE 22 Learn about program revisions and requirement updates. UnitedHealthcare Community Plan PAGE 29 Learn about Medicaid coverage changes and updates. UnitedHealthcare Medicare Advantage PAGE 35 Learn about Medicare policy, reimbursement and guideline changes. UnitedHealthcare Affiliates PAGE 37 Learn about updates with our company partners. PREV NEXT 2 | For more information, call 877-842-3210 or visit UHCprovider.com. UnitedHealthcare Network Bulletin October 2019 Table of Contents Front & Center Stay up to date with the latest news and information. Smart Edits Help Speed Up Radiology Program Outpatient Injectable Your Claims Cycle Procedure Code Changes Chemotherapy and Our Smart Edits claims tool catches Effective Jan. 1, 2020, Related Cancer Therapies errors and gives you an opportunity UnitedHealthcare will update Prior Authorization/ to resolve and resubmit a claim the procedure code list for the Notification Updates before it enters the claims cycle.
    [Show full text]
  • Tobacco Use: a Smart Guide
    1 Tobacco Use: A Smart Guide “STOPPING TAKES HARD WORK AND A LOT OF EFFORT, BUT – YOU CAN STOP TOBACCO” THE PROCESS OF QUITTING Do you find quitting tobacco difficult? The reason you continue to use tobacco is not because you are weak-willed or irresponsible, but because you are addicted. Nicotine is said to be more addictive than brown sugar (heroin) or cocaine. That is why people find it so difficult to stop, once they are habituated. The quitting process involves three steps: A. Preparation before quitting B. Actual quitting and C. Life after quitting. This manual will guide you through each of these steps. YOU NEED TO KNOW Before trying to quit tobacco you need to know a few facts about tobacco: • Tobacco comes in different forms….and all contain nicotine, the addictive substance. • Smoking forms of tobacco are beedis, cigarettes, cigars, chuttas, dhumti, pipe, hooklis, and hookah. • Smokeless forms of tobacco include chewing paan (betel quid) with zarda (tobacco), guthka, pan masala, manipuri tobacco, mawa, khaini, kaddi pudi, chewing tobacco leaves, mishri, gul, snuff, tobacco tooth paste and as tobacco water. Tobacco Facts • Tobacco is the leading cause of preventable death. • Each year tobacco kills 40,00,000 people. 2500 Indians die EVERYDAY due to tobacco related diseases. Deaths from tobacco use world wide are more than that from cocaine, heroin, alcohol, fires, accidents, murder, suicide, and AIDS COMBINED. • If you use tobacco, you are likely to die 15 years earlier. Tobacco Use: A Smart Guide 2 • Tobacco affects all the organs in the body from head to toe.
    [Show full text]
  • Opioid Prescriber Reference Guide
    Community Plan of Pennsylvania (Medicaid) Quick reference guide Opioid overutilization prevention and opioid use disorder treatment programs for UnitedHealthcare Community Plan of Pennsylvania (Medicaid) In response to the U.S. opioid epidemic, we’ve developed programs to help our members receive the care and treatment they need in safe and effective ways. We’ve based our measures on the Centers for Disease Control and Prevention’s (CDC) opioid treatment guidelines to help prevent overuse of short-acting and long-acting opioid medications. Please use this quick reference guide to learn more about what we offer. Concurrent Drug Utilization Review (cDUR) programs The cDUR program uses the pharmacy claims processing system to screen all prescriptions at the point of service and checks for possible inappropriate drug prescribing and utilization, as well as potentially dangerous medical implications or drug interactions. The program includes communication to the dispensing pharmacy at point-of-service through claims edits and messaging to the dispensing pharmacy at point of service. The pharmacist will need to address the clinical situation at the point of sale before entering appropriate National Council for Prescription Drug Programs (NCPDP) codes to receive an approved claim, unless otherwise stated below. • Combination opioids plus acetaminophen (APAP) limit THERDOSE Acetaminophen • Prevents doses of APAP greater than 4 grams per day Duplicate Therapy – • Alerts to concurrent use of multiple SAOs Short-Acting Opioids (SAOs) Duplicate Therapy
    [Show full text]
  • Does Areca Nut Use Lead to Dependence? Vivek Benegal ∗, Ravi P
    This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word or Tex form) to their personal website or institutional repository. Authors requiring further information regarding Elsevier’s archiving and manuscript policies are encouraged to visit: http://www.elsevier.com/copyright Author's personal copy Available online at www.sciencedirect.com Drug and Alcohol Dependence 97 (2008) 114–121 Does areca nut use lead to dependence? Vivek Benegal ∗, Ravi P. Rajkumar, Kesavan Muralidharan Deaddiction Centre, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore 560029, India Received 14 February 2007; received in revised form 24 March 2008; accepted 24 March 2008 Available online 19 May 2008 Abstract Background: The areca nut is consumed by approximately 10% of the world’s population, and its consumption is associated with long-term health risks, with or without tobacco additives. However, it is not known whether its use is associated with a dependence syndrome, as is seen with other psychoactive substances. Objective: To examine whether areca nut usage (with or without tobacco additives) could lead to the development of a dependence syndrome. Methods: Three groups: [a] persons using areca nut preparations without tobacco additives [n = 98]; [b] persons using areca nut preparations with tobacco additives [n = 44]; and [c] ‘Non-users’ were systematically assessed using a checklist for the use of areca or areca + tobacco products, patterns of use, presence of a dependence syndrome in users, features of stimulant withdrawal and desired/beneficial effects.
    [Show full text]
  • Decision of the Minister of Health No. 1853515 on Approval of The
    Unofficial Translation 22 Um Al- Friday 22 Rabea al-Awwal 1440 A.H - 30 Decisions & Laws Um Al-Qura Qura November 2018 Year 96 Year 96, Vol. 4755 [logo] Ministry of Health Decisions of the Ministry of Health Decision of the Minister of Health No. 1853515 on 29/12/ 1439 AH Approval on the Amendment of the Executive Regulation of Tobacco Control Law The Minister of Health, According to the authorities vested in him; After reviewing the Tobacco Law issued by the Royal Decree No. (M/56) on 28/07/1436 A.H; After reviewing Article 19 of Clause 1 of the Executive Regulation of Tobacco Control Law, which set forth that "The Ministry of Health reviews the Regulation one year from its enforcement and amends the same as it may requires". And as dictated by the public interest. Decided that: First: Approve the amendment to the Executive Regulation of Tobacco Control Law according to the form attached herewith: Second: This Regulation shall be published in the Official Gazette and on the Minister website and shall be put into force as of the date of its publication. Respectfully, Minister of Health Tawfiq bin Fawzran Al Rabiah Unofficial Translation 22 Um Al- Friday 22 Rabea al-Awwal 1440 A.H - 30 Decisions & Laws Um Al-Qura Qura November 2018 Year 96 Year 96, Vol. 4755 Executive Regulation of Tobacco Control Law Article 1: Law: This Law aims to control tobacco, by applying all the necessary procedures and steps in the State, society and individuals; reducing all forms of smoking habits at different ages.
    [Show full text]
  • Quick Reference Guide: Opioid Overutilization Prevention And
    Community Plan of Rhode Island Quick reference guide Opioid prevention and opioid use disorder treatment programs for UnitedHealthcare Community Plan of Rhode Island In response to the U.S. opioid epidemic, we’ve developed programs to help our members receive the care and treatment they need in safe and effective ways. We’ve based our measures on the Centers for Disease Control and Prevention’s (CDC) opioid treatment guidelines to help prevent overuse of short-acting and long-acting opioid medications. Please use this quick reference guide for information on what we offer. Concurrent Drug Utilization Review (cDUR) programs The cDUR program uses the pharmacy claims processing system to screen all prescriptions at the point of service and checks for possible inappropriate drug prescribing and utilization, as well as potentially dangerous medical implications or drug interactions. The program includes communication to the dispensing pharmacy at point of service through claims edits and messaging to the dispensing pharmacy at point of service. The pharmacist will need to address the clinical situation at the point of sale before entering appropriate NCPDP codes to receive an approved claim, unless otherwise stated below. • Combination opioids plus acetaminophen (APAP) limit THERDOSE Acetaminophen • Prevents doses of APAP greater than 4 grams per day Duplicate Therapy – • Alerts to concurrent use of multiple SAOs Short-Acting Opioids (SAOs) Duplicate Therapy – • Alerts to concurrent use of multiple LAOs Long-Acting Opioids (LAOs) Drug-Drug
    [Show full text]
  • Caitlyn D. Placek Curriculum Vitae July 2021
    Caitlyn D. Placek Curriculum Vitae July 2021 Department of Anthropology Email: [email protected] Ball State University Phone: 765-285-1170 Muncie, IN 47306 Centerstone Research Institute Email: [email protected] Bloomington, IN 47403 AREAS OF SPECIALIZATION Medical Anthropology • Public Health • Global Health • Mixed Methods • Substance Use • Dietary Patterns • Maternal Health • Program Evaluation • South Asia EMPLOYMENT 2017-current Ball State University Assistant Professor of Biological Anthropology 2020-current Centerstone Research Institute Lead Program Evaluator 2016- 2017 National Institutes of Health Global Health Equity Scholars Postdoctoral Fellow, Robert Stempel College of Public Health & Social Work, Florida International University AFFILIATIONS 2018-2020 Applied Anthropology Laboratory, Ball State University, Muncie, IN 2014- 2018 Public Health Research Institute of India, Mysore, Karnataka EDUCATION 2011- 2016 PhD, Anthropology, Washington State University 2009- 2011 MA, Anthropology, Washington State University 2004- 2008 BA, Anthropology, Eastern Kentucky University 2004- 2008 BS, Psychology, Eastern Kentucky University PUBLICATIONS Peer-Reviewed Journal Articles (undergraduate trainee co-authors underlined) 2021 29 Hlay J. K., Albert G., Batres C., Richardson G., Placek C., Arnocky S., Lieberman D., Hodges-Simeon, C. R. The evolution of disgust for pathogen detection and avoidance. Scientific Reports. 28 Placek C. D., Place J., Wies J. Reflections and challenges of pregnant and postpartum participant recruitment in the context of the opioid epidemic. Maternal and Child Health Caitlyn D. Placek 1 Journal, 1-5. 27 Placek C. D., Jaykrishna P., Srinivas V., Madhivanan P. M. Pregnancy fasting in Ramadan: Towards a Biocultural Framework. Ecology of Food and Nutrition, 1-25. 26 Urassa M., Lawson D., Wamoyi J., Gurmu E., Gibson M., Madhivanan P., Placek C.
    [Show full text]
  • Litigation Relevant to Regulation of Novel and Emerging Nicotine and Tobacco Products
    Case summaries LITIGATION RELEVANT TO REGULATION OF NOVEL AND EMERGING NICOTINE AND TOBACCO PRODUCTS COMPARISONCASE SUMMARIES ACROSS JURISDICTIONS Benn McGrady and Kritika Khanijo A Case summaries B Case summaries LITIGATION RELEVANT TO REGULATION OF NOVEL AND EMERGING NICOTINE AND TOBACCO PRODUCTS CASE SUMMARIES C Litigation relevant to regulation of novel and emerging nicotine and tobacco products: case summaries ISBN 978-92-4-002418-2 (electronic version) ISBN 978-92-4-002419-9 (print version) © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).
    [Show full text]
  • Community Information Drugs and Alcohol Factsheet 1 - Drugs and Drug Problems
    Community Information Drugs and Alcohol Factsheet 1 - Drugs and Drug Problems Created by Foundation for Local Development Thailand www.fldasia.org February 2014 1 Drugs and Alcohol – Factsheet 1: Drugs and Drug Problems 2 COMMUNITY INFORMATION - Ethnic Peace Resources Project (www.eprpinformation.org) This Factsheet explains what drugs are, their effects and the problems they can cause for people. What is a drug? A drug is: “a chemical substance that affects the body in some way”. A drug can affect different parts of the body, such as the kidneys or liver or stomach or heart or the brain. There are many different types of drugs. Most drugs are made in laboratories, although some drugs come from plants. When they are made from plants they are usually called “herbs”. Different types of drugs Drugs are used to manage sickness (such as those that are used to treat malaria or infections) or improve health (such as vitamins or herbs). Drugs that are used to manage sickness or to improve health are also called medicines. The word “drug” is often used to describe those substances that are taken for recreation. That is, a substance taken not to fix illness or improve health, but because a person wants the effect the drug has on their mood, their level of alertness, and their perceptions. Some drugs that people use for recreation are legal (alcohol, betel nuts, tobacco). Other drugs that people use for recreation are illegal (opium, heroin, marijuana and amphetamines, yaba, ya-ice). Why do people use drugs? People use drugs for many reasons including: • Medical: Doctors prescribe drugs (medicines) for illnesses such as infections, malaria, diabetes.
    [Show full text]